Comments on: Risks and benefits – what if Merck starts selling Vioxx again?

By: Bernie Simon

Bernie Simon — Sat, 19 Feb 2005 01:28:29 +0000

If Cox 2 inhibitors were developed because of their supposed lower side effects profile, not because of their enhanced effectiveness, and they turn out in fact to have a higher side effect profile, what good are they? To the patient, I mean, and not to the drug industry balance sheet. Pull them from the market. Seems like a no-brainer to me. OT: New study shows flu vaccine doesn't reduce death in the elderly.

By: BladeDoc

BladeDoc — Fri, 18 Feb 2005 21:56:29 +0000

The FDA just found that the cardiac risk seems to be a class effect (all COX II’s) — will you stop using all the drugs or go back to using Vioxx? I figure in my patients I’ll start with a non-selective NSAID and only go to a II for those without cardiac risks and WITH complications.

BladeDoc

By: Joshua

Joshua — Fri, 18 Feb 2005 15:55:20 +0000

I’m an ER resident who has been reading hour website for a while….PLEASE GO BACK TO THE OLD FORMAT… This ine is really hard to read